DK0501354T3 - Antikataraktmiddel - Google Patents

Antikataraktmiddel

Info

Publication number
DK0501354T3
DK0501354T3 DK92103010.2T DK92103010T DK0501354T3 DK 0501354 T3 DK0501354 T3 DK 0501354T3 DK 92103010 T DK92103010 T DK 92103010T DK 0501354 T3 DK0501354 T3 DK 0501354T3
Authority
DK
Denmark
Prior art keywords
cataract
anticataract
cataract agent
chem
anticataract composition
Prior art date
Application number
DK92103010.2T
Other languages
Danish (da)
English (en)
Inventor
Shinji Ohmori
Ogata Kazumi
Yoshimasa Abe
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of DK0501354T3 publication Critical patent/DK0501354T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK92103010.2T 1991-02-27 1992-02-22 Antikataraktmiddel DK0501354T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11964591 1991-02-27

Publications (1)

Publication Number Publication Date
DK0501354T3 true DK0501354T3 (da) 1995-10-16

Family

ID=14766578

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92103010.2T DK0501354T3 (da) 1991-02-27 1992-02-22 Antikataraktmiddel

Country Status (9)

Country Link
EP (1) EP0501354B1 (cg-RX-API-DMAC7.html)
JP (1) JPH05112463A (cg-RX-API-DMAC7.html)
KR (1) KR0168459B1 (cg-RX-API-DMAC7.html)
AT (1) ATE122892T1 (cg-RX-API-DMAC7.html)
CA (1) CA2061133A1 (cg-RX-API-DMAC7.html)
DE (1) DE69202594T2 (cg-RX-API-DMAC7.html)
DK (1) DK0501354T3 (cg-RX-API-DMAC7.html)
ES (1) ES2072644T3 (cg-RX-API-DMAC7.html)
TW (1) TW207498B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2123555A1 (en) * 1993-06-07 1994-12-08 Shinji Ohmori Intraocular irrigating solution
CA2213266A1 (en) * 1996-09-04 1998-03-04 Hideki Tsuruoka Method for isolation and purification of s-(1,2-dicarboxyethyl) glutathione
WO1999055329A1 (fr) * 1998-04-27 1999-11-04 Senju Pharmaceutical Co., Ltd. Medicament contre la cataracte
CN101704785B (zh) * 2009-11-16 2012-02-29 东南大学 有机二羧酸和其盐及其制备方法

Also Published As

Publication number Publication date
DE69202594D1 (de) 1995-06-29
EP0501354B1 (en) 1995-05-24
EP0501354A1 (en) 1992-09-02
ES2072644T3 (es) 1995-07-16
ATE122892T1 (de) 1995-06-15
CA2061133A1 (en) 1992-08-28
JPH05112463A (ja) 1993-05-07
KR920016092A (ko) 1992-09-24
DE69202594T2 (de) 1995-09-28
TW207498B (cg-RX-API-DMAC7.html) 1993-06-11
KR0168459B1 (ko) 1999-01-15

Similar Documents

Publication Publication Date Title
ATE225770T1 (de) Difluoroprostaglandin-derivate und ihre anwendung
EP0493608A4 (en) Quinolonecarboxylic acid derivative
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
EP0826688A4 (en) PENTACYCLIC COMPOUNDS
FI914187A0 (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
PL308666A1 (en) Derivatives of 11,21-bisphenyl-19-norpregnan, method of obtaining them and pharmaceutical composition containing such derivatives
DE69623497D1 (de) 1-methylcarbapenem-derivate
DK0420121T3 (da) Antitumormiddel
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
GR3002692T3 (en) Benzoxazine derivatives and processes for preparation thereof
ES2072644T3 (es) Composicion anticataratas.
DK0420224T3 (da) Anthihepatopatisk middel
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE69424677D1 (de) Präparat zur behandlung der drogenabhängigkeit